Actuate Therapeutics, Inc. (ACTU)
0.3202
-0.01
(-2.08%)
USD |
NASDAQ |
Nov 06, 10:16
Actuate Therapeutics Shareholders Equity (Quarterly) : 0.9892M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.9892M |
| March 31, 2026 | 3.784M |
| December 31, 2025 | 7.924M |
| September 30, 2025 | 10.94M |
| June 30, 2025 | -2.654M |
| March 31, 2025 | -5.088M |
| Date | Value |
|---|---|
| December 31, 2024 | 0.1042M |
| September 30, 2024 | 5.359M |
| June 30, 2024 | -20.08M |
| March 31, 2024 | -13.60M |
| December 31, 2023 | -5.448M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| AbbVie, Inc. | -4.583B |
| ACADIA Pharmaceuticals, Inc. | 1.387B |
| Alnylam Pharmaceuticals, Inc. | 3.604B |
| Anika Therapeutics, Inc. | 137.28M |
| Savara, Inc. | 143.66M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 5.199M |
| Total Liabilities (Quarterly) | 4.210M |
| Debt to Equity Ratio | 0.4094 |
| Current Ratio | 1.248 |